BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33640803)

  • 1. Neuroendocrine carcinomas of the head and neck: A small case series.
    Mitchell MB; Kimura K; Chapurin N; Saab Chalhoub M; Mehrad M; Langerman A; Mannion K; Netterville J; Rohde S; Sinard R; Kim Y
    Am J Otolaryngol; 2021; 42(4):102992. PubMed ID: 33640803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
    Jo VY; Krane JF; Pantanowitz L; Monaco SE
    Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.
    Thompson ED; Stelow EB; Mills SE; Westra WH; Bishop JA
    Am J Surg Pathol; 2016 Apr; 40(4):471-8. PubMed ID: 26735857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
    Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
    Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic neuroendocrine carcinomas to the head and neck: report of 4 cases and review of the literature.
    Salama AR; Jham BC; Papadimitriou JC; Scheper MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):242-7. PubMed ID: 19615663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eight Cases of Small Cell Neuroendocrine Carcinoma of the Head and Neck].
    Wakaoka T; Mizuta K; Shibata H; Hayashi H; Nishihori T; Kuze B; Aoki M; Ando K; Onishi M; Tanahashi S; Shirato H; Ito Y
    Nihon Jibiinkoka Gakkai Kaiho; 2017 Mar; 120(3):202-8. PubMed ID: 30010300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
    Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
    Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
    Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postirradiated neuroendocrine carcinoma of the sinonasal tract.
    Wang CP; Hsieh CY; Chang YL; Lou PJ; Yang TL; Ting LL; Ko JY
    Laryngoscope; 2008 May; 118(5):804-9. PubMed ID: 18520182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine Carcinomas of the Larynx and Head and Neck: Challenges in Classification and Grading.
    Perez-Ordoñez B
    Head Neck Pathol; 2018 Mar; 12(1):1-8. PubMed ID: 29557536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Grade Neuroendocrine Carcinoma of the Head and Neck: Human Papillomavirus Status and PD-L1 Expression.
    Bahr K; Zimmer S; Springer E; Fottner C; Becker S; Ernst BP; Matthias C; Künzel J
    ORL J Otorhinolaryngol Relat Spec; 2019; 81(5-6):309-316. PubMed ID: 31550725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of small cell neuroendocrine carcinoma of the head and neck].
    Li ZJ; Li HZ; Liu WS; Xu ZG; Tang PZ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3275-8. PubMed ID: 19159554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine carcinoma of the head and neck: a 20-year case series.
    Meacham R; Matrka L; Ozer E; Ozer HG; Wakely P; Shah M
    Ear Nose Throat J; 2012 Mar; 91(3):E20-4. PubMed ID: 22430343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma.
    Terashima T; Morizane C; Hiraoka N; Tsuda H; Tamura T; Shimada Y; Kaneko S; Kushima R; Ueno H; Kondo S; Ikeda M; Okusaka T
    Neuroendocrinology; 2012; 96(4):324-32. PubMed ID: 22572060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.